evenfolio

Capital Goods · NSE: EPL

EPL

Q2 FY27 earnings and concall highlights

Price as of 16 Nov 2026
237.92+0.06%

Q2 FY27 earnings call · Guided by management

Call held 4 Nov 2026 · Read the filing on NSEFiling

20​%Underlying margin · near-termBakshi · p. 5
₹625–700​CrCapex · full yearBakshi · Q&A · p. 7
35–50​USD millionMerger synergy benefits · 3 years post mergerBakshi · Q&A · p. 10
90​%Capex · H1 FY27Bakshi · p. 4
M.Cap
₹7,622Cr
P/E
19.4×
1Y return
+18.76%
From 52W high
−13.2%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue1,5671,206+30.0%1,388+12.9%
EBITDA288252+14.5%261+10.3%
EBITDA margin18.4%20.9%-249 bps18.8%-45 bps
PBTProfit before tax152141+8.0%126+20.2%
Net profit110104+5.6%99+11.7%
EPS (₹)3.423.25+5.2%3.07+11.4%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue growth · FY2720%Revenue growth expected at high end of guidance, closer to 20%
EBITDA margin · FY2720%keptUnderlying margin guidance of 20% retained
EBITDA margin · long term20%Underlying EBITDA margin guided at 20% plus; Q2 came in at 20.4%
Capex · FY27Rs 625-700 CrFull-year capex expected at about INR 625 to 700 crore

Near-term revenue growth guidance of high teens retained

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 5
“We are retaining our near-term guidance of revenue growth in high teens and underlying margins of 20%.”

Revenue guidance covers the next few quarters, not only H2

Deepak Goyal · Chief Financial Officer · p. 14
“this guidance is now for the next few quarters and not only for H2 specifically, right?”

High-teens revenue growth guidance retained as Oral and B&C perform well

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 12
“And both our categories, oral and B&C are performing well. So, we feel very strong about our revenue projections going forward, and that's why we've retained our guidance of high teens”

More figures from the call

Company · Capacity
60–65​%Capacity utilisation
“So, we normally operate in the range of 60% to 65% utilization basis.”
M. R. Ramasamy · Chief Operating Officer · Q&Ap. 15
Company · Debt and working capital
0.2–0.25​×Debt-to-EBITDA ratio · post merger
“Post the merger, our debt-to-EBITDA ratio will be about 0.2, 0.25, and that will enable with a very strong balance sheet for us to look at inorganic opportunities”
Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&Ap. 11
Europe · Segments
2–3​quartersTime to stabilise operations · another 2 to 3 quarters
“Overall, we feel that it will take us another 2 to 3 quarters to fully stabilize operations and get margins back to the levels at which we want them to be.”
Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&Ap. 7

In short

  1. 01Near-term guidance of high-teens revenue growth and 20% underlying margin retained.
  2. 02Management expects revenue growth at the high end, closer to 20%, for the next 2 quarters.
  3. 03Q2 revenue grew 30% (20.3% underlying); underlying EBITDA margin 20.4%.
  4. 04Indovida merger expected to complete by Q4 of this year, subject to NCLT approval.
  5. 05Merger synergies of US$35 to 50 million expected in the 3 years after the merger.
  6. 06Europe expected to take 2 to 3 more quarters to stabilise operations and margins.
  7. 07PAT grew 5.6% due to higher depreciation, tax rate and forex.

Capex

Capex may be moderated over time depending on need

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 7
“As we go forward, we will see how much investment is still required and whether some of this will get moderated over a period of time.”

B&C: Capex is all for growth, much of it for Beauty & Cosmetics

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“So, I think the answer to your question is our capex is all behind growth and a lot of it is behind B&C.”

B&C: Invested in extruded tube capabilities in China, India and Europe

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“We've invested in extruded tube capabilities in China. We've also made those investments in India and Europe.”

B&C: Invested in the U.S., a large B&C market where its B&C business was small

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“We've invested in U.S., which is a very significant B&C market where our business in B&C was relatively small.”

Building high-end printing and decoration capabilities

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“In addition to just capacity to produce more tubes, we are focused on building high-end advanced printing and decoration capabilities, which we are also in the process of executing as we speak.”

Capacity

B&C: Decided to build B&C capabilities and capacity ahead of the curve

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“So as I was saying, we feel very confident about our B&C business, and we've therefore decided that we will build capabilities and capacity ahead of the curve.”

Segments

Beauty & Cosmetics: Beauty & Cosmetics grew 42.9%; Oral Care grew 19.2%

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“Beauty & Cosmetics delivered exceptional performance at 42.9% growth, while Oral Care continued its strong performance with a growth of 19.2%.”

B&C: B&C revenue passed Oral Care in September, becoming the largest category

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“In the month of September, B&C revenues exceeded that of Oral Care, becoming our largest category.”

B&C, Oral: B&C and Oral Care are about 44% of the business each

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 10
“So, both our B&C and oral business are about 44% each.”

Regions: Regional growth: EAP 40%, Europe 30%, AMESA 28%, Americas 25%, India 30%

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“EAP led with revenue growth of 40%, followed by Europe at 30%, AMESA at 28% and Americas at 25%. India stand-alone also delivered robust growth of 30%.”

Thailand, Brazil: Thailand progressing with customer pipeline; Brazil delivering growth

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 5
“Thailand is progressing well, backed by a strong customer pipeline, while Brazil is a strong example of our ability to build momentum and translate market opportunities into sustained growth.”

Demand

B&C: Gained 130 bps of global B&C market share in the last year

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 6
“And in the last 1 year, we've gained 130 basis points of market share, which at a global level is a very significant achievement.”

Service actions including air freight earning market share gains

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“Going the extra mile to deliver superior service, including bearing higher cost of air freight, if necessary, we are being rewarded through gain in market share as a result of these bold actions.”

B&C India: Most B&C growth in India comes from existing customers

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 14
“Bulk of our growth is being driven by our existing customers.”

B&C: Extruded tubes make up almost 80% of the B&C market

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 14
“To give you an example, in B&C, extruded contributes to almost 80% of the market.”

B&C: In lower-share markets, B&C growth comes from customer acquisition

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 15
“Also in these markets, bulk of our growth is coming through customer acquisition.”

Margins and costs

Q2 EBITDA rose 17.6%; reported EBITDA margin 18.9%

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“EBITDA increased by 17.6%, with reported EBITDA margins at 18.9%.”

Underlying revenue grew 20.3%; underlying EBITDA margin 20.4%

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“On an underlying basis, excluding the pass-through impact of higher raw material prices, revenue grew by 20.3%, with underlying EBITDA margins at 20.4%.”

PAT grew 5.6%, held back by depreciation, tax rate and forex

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“PAT during this quarter grew by 5.6% due to higher depreciation, higher effective tax rate as a result of country mix and adverse forex movements.”

Full cost increases recovered through pricing

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“Despite continued cost pressures, we have successfully recovered the full impact of cost increases through pricing actions.”

Underlying gross margin 60.5% after excluding inflationary cost

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 12
“But if you look at it underlying, our gross margin or gross contribution after excluding the inflationary cost is 60.5%.”

Debt and working capital

Indovida has no debt; EPL debt is very low

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 11
“Indovida has no debt on its balance sheet. It's a completely cash-rich company. Our debt levels are also very, very low.”

Inventory levels raised and extra freight costs incurred to protect service

Deepak Goyal · Chief Financial Officer · Q&A · p. 13
“We have incurred additional freight costs. We have increased our inventory levels just to make sure that our OTIFs and customer service remains at a superior level”

Acquisitions and new business

Indovida merger has CCI, antitrust and exchange approvals; NCLT application filed

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“having received approvals from the Competition Commission of India, foreign antitrust authorities and the stock exchanges. We have now filed our application with the National Company Law Tribunal”

Merger expected to complete by Q4 of this year

Deepak Goyal · Chief Financial Officer · Q&A · p. 10
“We are expecting merger to get completed by Q4 of this year. And if everything goes well, then hopefully, our Q4 results will be the consolidated results.”

Share count after merger swap about 51 crore

Deepak Goyal · Chief Financial Officer · Q&A · p. 10
“51 crores, yes.”

Most merger synergy expected in revenue, some in cost savings

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 8
“There would also be some savings on costs. But I think the larger proportion of the synergy benefit will be on the top line.”

Indovida present in Nigeria, Ghana, Tanzania, Morocco where EPL is not

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 11
“They are present in countries like Nigeria, Ghana, Tanzania, Morocco, in Africa where we are not present.”

Risks

Middle East conflict keeping commodity prices high and disrupting supply chains

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“The ongoing conflict in Middle East is keeping commodity prices elevated and disrupting supply chains.”

Europe: Poland printing site approvals took 6 to 9 months longer, raising outsourcing costs

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 7
“It took us at least 6 to 9 months longer. And while we've continued to have higher demand, as this stabilization has taken some time, it has led to higher outsourcing costs.”

Prices moderated a bit with no real change; good H2 top line expected

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 9
“They've moderated a bit, but there is no real change. So yes, we should see a good top line in the second half of the year as well.”

Merger timing depends on NCLT approvals, which are still pending

Deepak Goyal · Chief Financial Officer · Q&A · p. 10
“But this is obviously dependent on the NCLT approvals, which are still pending and hence, no one can be certain, but we are hoping that we can still present Q4 results at consolidated levels.”

Input prices expected to remain elevated for now

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 9
“Having said that, prices will remain elevated at this point in time.”

Other

Q2 revenue grew 30%, the highest growth EPL has reported

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“Revenue for the quarter grew by 30%. This is the highest ever growth that EPL has ever declared.”

16th consecutive quarter of double-digit EBITDA growth

17.6​%
Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 3
“Our EBITDA continued its strong momentum, growing by 17.6% and marking our 16th consecutive quarter of double-digit EBITDA growth, demonstrating our ability to sustain growth while maintaining profitability.”

Sustainable tubes are 41% of product mix

Hemant Bakshi · Managing Director and Global Chief Executive Officer · p. 4
“We have also advanced our sustainable packaging portfolio, with sustainable tubes accounting for 41% of our product mix.”

Sales front end split into separate Oral and B&C teams

Hemant Bakshi · Managing Director and Global Chief Executive Officer · Q&A · p. 15
“One significant decision we took recently was to completely divisionalize our front end. So, our sales people now for oral and B&C are distinct.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools